Skip to main content

ZBTB8B Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-83789

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-83789-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of Human ZBTB8B. Peptide sequence: LVEASSESQEKSDTDNDWPIYVESGEENDPAGDDSDDKPQIQPNLSDRET The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for ZBTB8B Antibody

Western Blot: ZBTB8B Antibody [NBP2-83789]

Western Blot: ZBTB8B Antibody [NBP2-83789]

Western Blot: ZBTB8B Antibody [NBP2-83789] - Host: Rabbit. Target Name: ZBTB8B. Sample Tissue: Human MCF7 Whole Cell. Antibody Dilution: 1ug/ml

Applications for ZBTB8B Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: ZBTB8B

Alternate Names

DKFZp547H154, RP1-27O5.1, zinc finger and BTB domain containing 8B, zinc finger and BTB domain-containing protein 8B, ZNF916B

Gene Symbol

ZBTB8B

Additional ZBTB8B Products

Product Documents for ZBTB8B Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ZBTB8B Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...